{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:10:34Z","timestamp":1787242234603,"version":"build-2736575974"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001169","name":"Cancer Council Tasmania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001169","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012503","name":"Royal Hobart Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012503","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40271-025-00784-0","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:32:28Z","timestamp":1762788748000},"page":"197-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Systematic Review of Patient-Reported Measures for Individuals Who Underwent Genetic Testing for Heritable Cancer"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8463-6820","authenticated-orcid":false,"given":"Kelsie","family":"Raspin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne L.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Roydhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"784_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41571-018-0002-6","volume":"15","author":"MF Berger","year":"2018","unstructured":"Berger MF, Mardis ER. The emerging clinical relevance of genomics in cancer medicine. Nat Rev Clin Oncol. 2018;15:353\u201365. https:\/\/doi.org\/10.1038\/s41571-018-0002-6.","journal-title":"Nat Rev Clin Oncol"},{"key":"784_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100251","volume":"11","author":"N Swami","year":"2022","unstructured":"Swami N, Yamoah K, Mahal BA, Dee EC. The right to be screened: identifying and addressing inequities in genetic screening. Lancet Reg Health Am. 2022;11:100251. https:\/\/doi.org\/10.1016\/j.lana.2022.100251.","journal-title":"Lancet Reg Health Am"},{"key":"784_CR3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.10595","author":"VN Giri","year":"2022","unstructured":"Giri VN, Hartman RL, Gross L, Keith SW. Patient-reported outcomes among males undergoing prostate cancer germline testing: interim results from the Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS) registry. J Clin Oncol. 2022. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.10595.","journal-title":"J Clin Oncol"},{"key":"784_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3389\/fgene.2018.00624","volume":"9","author":"S Oliveri","year":"2018","unstructured":"Oliveri S, Ferrari F, Manfrinati A, Pravettoni G. A systematic review of the psychological implications of genetic testing: a comparative analysis among cardiovascular, neurodegenerative and cancer diseases. Front Genet. 2018;9:624. https:\/\/doi.org\/10.3389\/fgene.2018.00624.","journal-title":"Front Genet"},{"key":"784_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"USDO Health","year":"2006","unstructured":"Health USDO, et al. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79. https:\/\/doi.org\/10.1186\/1477-7525-4-79.","journal-title":"Health Qual Life Outcomes"},{"key":"784_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00520-017-3865-7","volume":"26","author":"LY Yang","year":"2018","unstructured":"Yang LY, Manhas DS, Howard AF, Olson RA. Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication. Support Care Cancer. 2018;26:41\u201360. https:\/\/doi.org\/10.1007\/s00520-017-3865-7.","journal-title":"Support Care Cancer"},{"key":"784_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch E, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318:197\u20138. https:\/\/doi.org\/10.1001\/jama.2017.7156.","journal-title":"JAMA"},{"key":"784_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-104","volume":"8","author":"EA Laugsand","year":"2010","unstructured":"Laugsand EA, et al. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes. 2010;8:104. https:\/\/doi.org\/10.1186\/1477-7525-8-104.","journal-title":"Health Qual Life Outcomes"},{"key":"784_CR9","unstructured":"Mapi Research Trust. n.d. ePROVIDE: COA databases. Accessed 10 September. <ePROVIDE database by Mapi Research Trust>."},{"key":"784_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/jmedgenet-2020-107416","volume":"59","author":"SY Yoon","year":"2022","unstructured":"Yoon SY, et al. Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes. J Med Genet. 2022;59:220\u20139. https:\/\/doi.org\/10.1136\/jmedgenet-2020-107416.","journal-title":"J Med Genet"},{"key":"784_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10689-013-9644-9","volume":"12","author":"AS Sie","year":"2013","unstructured":"Sie AS, Prins JB, Spruijt L, Kets CM, Hoogerbrugge N. Can we test for hereditary cancer at 18\u00a0years when we start surveillance at 25? Patient reported outcomes. Fam Cancer. 2013;12:675\u201382. https:\/\/doi.org\/10.1007\/s10689-013-9644-9.","journal-title":"Fam Cancer"},{"key":"784_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1399-0004.2008.01089.x","volume":"74","author":"M Keller","year":"2008","unstructured":"Keller M, et al. Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members. Clin Genet. 2008;74:414\u201324. https:\/\/doi.org\/10.1111\/j.1399-0004.2008.01089.x.","journal-title":"Clin Genet"},{"key":"784_CR13","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1038\/s41436-021-01288-6","volume":"23","author":"T Yanes","year":"2021","unstructured":"Yanes T, et al. Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior. Genet Med. 2021;23:2316\u201323. https:\/\/doi.org\/10.1038\/s41436-021-01288-6.","journal-title":"Genet Med"},{"key":"784_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/jnci\/89.2.148","volume":"89","author":"C Lerman","year":"1997","unstructured":"Lerman C, et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst. 1997;89:148\u201357. https:\/\/doi.org\/10.1093\/jnci\/89.2.148.","journal-title":"J Natl Cancer Inst"},{"key":"784_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pec.2004.02.007","volume":"56","author":"J Erblich","year":"2005","unstructured":"Erblich J, et al. Development and validation of a breast cancer genetic counseling knowledge questionnaire. Patient Educ Couns. 2005;56:182\u201391. https:\/\/doi.org\/10.1016\/j.pec.2004.02.007.","journal-title":"Patient Educ Couns"},{"key":"784_CR16","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.pec.2019.04.014","volume":"102","author":"M Underhill-Blazey","year":"2019","unstructured":"Underhill-Blazey M, et al. Development and testing of the KnowGene scale to assess general cancer genetic knowledge related to multigene panel testing. Patient Educ Couns. 2019;102:1558\u201364. https:\/\/doi.org\/10.1016\/j.pec.2019.04.014.","journal-title":"Patient Educ Couns"},{"key":"784_CR17","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","volume":"275","author":"C Lerman","year":"1996","unstructured":"Lerman C, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996;275:1885\u201392. https:\/\/doi.org\/10.1001\/jama.1996.03530480027036.","journal-title":"JAMA"},{"key":"784_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/107327480401100405","volume":"11","author":"K Kelly","year":"2004","unstructured":"Kelly K, et al. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1\/2 mutations. Cancer Control. 2004;11:236\u201344. https:\/\/doi.org\/10.1177\/107327480401100405.","journal-title":"Cancer Control"},{"key":"784_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/gim.2012.22","volume":"14","author":"KA Kaphingst","year":"2012","unstructured":"Kaphingst KA, et al. Patients\u2019 understanding of and responses to multiplex genetic susceptibility test results. Genet Med. 2012;14:681\u20137. https:\/\/doi.org\/10.1038\/gim.2012.22.","journal-title":"Genet Med"},{"key":"784_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/cge.13716","volume":"97","author":"AR Bradbury","year":"2020","unstructured":"Bradbury AR, et al. Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1\/2 negative patients. Clin Genet. 2020;97:601\u20139. https:\/\/doi.org\/10.1111\/cge.13716.","journal-title":"Clin Genet"},{"key":"784_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1089\/tmj.2017.0073","volume":"24","author":"NM Solomons","year":"2018","unstructured":"Solomons NM, Lamb AE, Lucas FL, McDonald EF, Miesfeldt S. Examination of the patient-focused impact of cancer telegenetics among a rural population: comparison with traditional in-person services. Telemed J E Health. 2018;24:130\u20138. https:\/\/doi.org\/10.1089\/tmj.2017.0073.","journal-title":"Telemed J E Health"},{"key":"784_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/gtmb.2020.0275","volume":"25","author":"AA Lemke","year":"2021","unstructured":"Lemke AA, et al. Patient-reported outcomes and experiences with population genetic testing offered through a primary care network. Genet Test Mol Biomarkers. 2021;25:152\u201360. https:\/\/doi.org\/10.1089\/gtmb.2020.0275.","journal-title":"Genet Test Mol Biomarkers"},{"key":"784_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106821","volume":"119","author":"S Loeb","year":"2022","unstructured":"Loeb S, et al. Technology-enhanced acceleration of germline evaluation for therapy (TARGET): a randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing. Contemp Clin Trials. 2022;119:106821. https:\/\/doi.org\/10.1016\/j.cct.2022.106821.","journal-title":"Contemp Clin Trials"},{"key":"784_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/jgc4.1317","volume":"30","author":"M Underhill-Blazey","year":"2021","unstructured":"Underhill-Blazey M, et al. Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations. J Genet Couns. 2021;30:268\u201382. https:\/\/doi.org\/10.1002\/jgc4.1317.","journal-title":"J Genet Couns"},{"key":"784_CR25","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00199","author":"MJ Hall","year":"2018","unstructured":"Hall MJ, et al. Use and patient-reported outcomes of clinical multigene panel testing for cancer susceptibility in the multicenter communication of genetic test results by telephone study. JCO Precis Oncol. 2018. https:\/\/doi.org\/10.1200\/PO.18.00199.","journal-title":"JCO Precis Oncol"},{"key":"784_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0272989X10381283","volume":"31","author":"GW Hooker","year":"2011","unstructured":"Hooker GW, et al. Longitudinal changes in patient distress following interactive decision aid use among BRCA1\/2 carriers: a randomized trial. Med Decis Making. 2011;31:412\u201321. https:\/\/doi.org\/10.1177\/0272989X10381283.","journal-title":"Med Decis Making"},{"key":"784_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkx002","volume":"1","author":"MK Interrante","year":"2017","unstructured":"Interrante MK, et al. Randomized noninferiority trial of telephone vs in-person genetic counseling for hereditary breast and ovarian cancer: a 12-month follow-up. JNCI Cancer Spectr. 2017;1:pkx002. https:\/\/doi.org\/10.1093\/jncics\/pkx002.","journal-title":"JNCI Cancer Spectr"},{"key":"784_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpsychores.2016.08.005","volume":"89","author":"A Oberguggenberger","year":"2016","unstructured":"Oberguggenberger A, et al. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: a patient-reported outcome study. J Psychosom Res. 2016;89:39\u201345. https:\/\/doi.org\/10.1016\/j.jpsychores.2016.08.005.","journal-title":"J Psychosom Res"},{"key":"784_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10552-021-01398-1","volume":"32","author":"S Makhnoon","year":"2021","unstructured":"Makhnoon S, et al. The familytalk randomized controlled trial: patient-reported outcomes in clinical genetic sequencing for colorectal cancer. Cancer Causes Control. 2021;32:483\u201392. https:\/\/doi.org\/10.1007\/s10552-021-01398-1.","journal-title":"Cancer Causes Control"},{"key":"784_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1037\/0278-6133.21.6.564","volume":"21","author":"D Cella","year":"2002","unstructured":"Cella D, et al. A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol. 2002;21:564\u201372. https:\/\/doi.org\/10.1037\/0278-6133.21.6.564.","journal-title":"Health Psychol"},{"key":"784_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/cge.12473","volume":"87","author":"W Eijzenga","year":"2015","unstructured":"Eijzenga W, et al. Routine assessment of psychosocial problems after cancer genetic counseling: results from a randomized controlled trial. Clin Genet. 2015;87:419\u201327. https:\/\/doi.org\/10.1111\/cge.12473.","journal-title":"Clin Genet"},{"key":"784_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13928","volume":"26","author":"SE Wing","year":"2021","unstructured":"Wing SE, et al. Recall of genomic testing results among patients with cancer. Oncologist. 2021;26:e2302\u2013e2305. https:\/\/doi.org\/10.1002\/onco.13928.","journal-title":"Oncologist"},{"key":"784_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10897-014-9750-3","volume":"24","author":"J Armstrong","year":"2015","unstructured":"Armstrong J, et al. American BRCA outcomes and utilization of testing (ABOUT) study: a pragmatic research model that incorporates personalized medicine\/patient-centered outcomes in a real world setting. J Genet Counsel. 2015;24:18\u201328. https:\/\/doi.org\/10.1007\/s10897-014-9750-3.","journal-title":"J Genet Counsel"},{"key":"784_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.22092","volume":"5","author":"R Kukafka","year":"2022","unstructured":"Kukafka R, et al. Patient and clinician decision support to increase genetic counseling for hereditary breast and ovarian cancer syndrome in primary care: a cluster randomized clinical trial. JAMA Netw Open. 2022;5:e2222092. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.22092.","journal-title":"JAMA Netw Open"},{"key":"784_CR35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s10897-015-9897-6","volume":"25","author":"BN Peshkin","year":"2016","unstructured":"Peshkin BN, et al. Patient perceptions of telephone vs. in-person BRCA1\/BRCA2 genetic counseling. J Genet Couns. 2016;25:472\u201382. https:\/\/doi.org\/10.1007\/s10897-015-9897-6.","journal-title":"J Genet Couns"},{"key":"784_CR36","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00238","author":"J Russo","year":"2021","unstructured":"Russo J, et al. Pretest genetic education video versus genetic counseling for men considering prostate cancer germline testing: a patient-choice study to address urgent practice needs. JCO Precis Oncol. 2021. https:\/\/doi.org\/10.1200\/PO.21.00238.","journal-title":"JCO Precis Oncol"},{"key":"784_CR37","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/BF02895156","volume":"19","author":"J Audrain","year":"1997","unstructured":"Audrain J, et al. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med. 1997;19:370\u20137. https:\/\/doi.org\/10.1007\/BF02895156.","journal-title":"Ann Behav Med"},{"key":"784_CR38","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.8.4.e27","volume":"8","author":"CD Norman","year":"2006","unstructured":"Norman CD, Skinner HA. eHEALS: The eHealth Literacy Scale. J Med Internet Res. 2006;8:e27. https:\/\/doi.org\/10.2196\/jmir.8.4.e27.","journal-title":"J Med Internet Res"},{"key":"784_CR39","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/s41436-021-01262-2","volume":"23","author":"JG Hamilton","year":"2021","unstructured":"Hamilton JG, et al. Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer. Genet Med. 2021;23:2105\u201313. https:\/\/doi.org\/10.1038\/s41436-021-01262-2.","journal-title":"Genet Med"},{"key":"784_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr Scand"},{"key":"784_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1037\/0278-6133.10.4.259","volume":"10","author":"C Lerman","year":"1991","unstructured":"Lerman C, et al. Psychological side effects of breast cancer screening. Health Psychol. 1991;10:259\u201367. https:\/\/doi.org\/10.1037\/0278-6133.10.4.259.","journal-title":"Health Psychol"},{"key":"784_CR42","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1200\/JCO.2014.55.4576","volume":"32","author":"W Eijzenga","year":"2014","unstructured":"Eijzenga W, et al. Effect of routine assessment of specific psychosocial problems on personalized communication, counselors\u2019 awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial. J Clin Oncol. 2014;32:2998\u20133004. https:\/\/doi.org\/10.1200\/JCO.2014.55.4576.","journal-title":"J Clin Oncol"},{"key":"784_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","volume":"41","author":"M Horowitz","year":"1979","unstructured":"Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41:209\u201318. https:\/\/doi.org\/10.1097\/00006842-197905000-00004.","journal-title":"Psychosom Med"},{"key":"784_CR44","unstructured":"State Insurance Regulatory Authority: guidelines for the management of acute whiplash-associated disorders\u2014For health professionals. 3rd Edition, 47 (2014)."},{"key":"784_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0272989X9501500105","volume":"15","author":"AM O\u2019Connor","year":"1995","unstructured":"O\u2019Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15:25\u201330. https:\/\/doi.org\/10.1177\/0272989X9501500105.","journal-title":"Med Decis Making"},{"key":"784_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1023\/b:jogc.0000035523.96133.bc","volume":"13","author":"TA DeMarco","year":"2004","unstructured":"DeMarco TA, Peshkin BN, Mars BD, Tercyak KP. Patient satisfaction with cancer genetic counseling: a psychometric analysis of the genetic counseling satisfaction scale. J Genet Couns. 2004;13:293\u2013304. https:\/\/doi.org\/10.1023\/b:jogc.0000035523.96133.bc.","journal-title":"J Genet Couns"},{"key":"784_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1046\/j.1369-6513.1998.00004.x","volume":"1","author":"HJ Sixma","year":"1998","unstructured":"Sixma HJ, Kerssens JJ, Campen CV, Peters L. Quality of care from the patients\u2019 perspective: from theoretical concept to a new measuring instrument. Health Expect. 1998;1:82\u201395. https:\/\/doi.org\/10.1046\/j.1369-6513.1998.00004.x.","journal-title":"Health Expect"},{"key":"784_CR48","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/jmg-2024-109845","volume":"61","author":"R Hall","year":"2024","unstructured":"Hall R, Bancroft E, Pashayan N, Kote-Jarai Z, Eeles RA. Genetics of prostate cancer: a review of latest evidence. J Med Genet. 2024;61:915\u201326. https:\/\/doi.org\/10.1136\/jmg-2024-109845.","journal-title":"J Med Genet"},{"key":"784_CR49","doi-asserted-by":"publisher","first-page":"7943","DOI":"10.1002\/cam4.4307","volume":"10","author":"J Lai-Kwon","year":"2021","unstructured":"Lai-Kwon J, Yin Z, Minchom A, Yap C. Trends in patient-reported outcome use in early phase dose-finding oncology trials - an analysis of ClinicalTrials.gov. Cancer Med. 2021;10:7943\u201357. https:\/\/doi.org\/10.1002\/cam4.4307.","journal-title":"Cancer Med"},{"key":"784_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/pros.24447","volume":"83","author":"JB Harper","year":"2023","unstructured":"Harper JB, Greenberg SE, Hunt TC, Cooney KA, O\u2019Neil BB. Initial outcomes and insights from a novel high-risk prostate cancer screening clinic. Prostate. 2023;83:151\u20137. https:\/\/doi.org\/10.1002\/pros.24447.","journal-title":"Prostate"},{"key":"784_CR51","unstructured":"The Genetic Information Non-Discrimination Act, Public Law 110\u2013223. http:\/\/www.gpo.gov\/fdsys\/pkg\/PLAW-110publ233\/pdf\/PLAW-110publ233.pdf."},{"key":"784_CR52","unstructured":"Charter of Fundamental Rights of the European Union. https:\/\/www.europarl.europa.eu\/charter\/pdf\/text_en.pdf."},{"key":"784_CR53","doi-asserted-by":"publisher","first-page":"1190421","DOI":"10.3389\/fgene.2023.1190421","volume":"14","author":"D Patrinos","year":"2023","unstructured":"Patrinos D, Ghaly M, Al-Shafai M, Zawati MH. Legal approaches to risk of harm in genetic counseling: perspectives from Quebec and Qatar. Front Genet. 2023;14:1190421. https:\/\/doi.org\/10.3389\/fgene.2023.1190421.","journal-title":"Front Genet"},{"key":"784_CR54","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1038\/s41467-022-32707-0","volume":"13","author":"J Luke","year":"2022","unstructured":"Luke J, et al. Investigating disparity in access to Australian clinical genetic health services for Aboriginal and Torres Strait Islander people. Nat Commun. 2022;13:4966. https:\/\/doi.org\/10.1038\/s41467-022-32707-0.","journal-title":"Nat Commun"},{"key":"784_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12910-021-00720-5","volume":"22","author":"T Ascencio-Carbajal","year":"2021","unstructured":"Ascencio-Carbajal T, Saruwatari-Zavala G, Navarro-Garcia F, Frixione E. Genetic\/genomic testing: defining the parameters for ethical, legal and social implications (ELSI). BMC Med Ethics. 2021;22:156. https:\/\/doi.org\/10.1186\/s12910-021-00720-5.","journal-title":"BMC Med Ethics"},{"key":"784_CR56","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41431-019-0368-7","volume":"27","author":"J Liddicoat","year":"2019","unstructured":"Liddicoat J, et al. Continental drift? Do European clinical genetic testing laboratories have a patent problem? Eur J Hum Genet. 2019;27:997\u20131007. https:\/\/doi.org\/10.1038\/s41431-019-0368-7.","journal-title":"Eur J Hum Genet"},{"key":"784_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100803","volume":"25","author":"A Abu-El-Haija","year":"2023","unstructured":"Abu-El-Haija A, et al. The clinical application of polygenic risk scores: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2023;25:100803. https:\/\/doi.org\/10.1016\/j.gim.2023.100803.","journal-title":"Genet Med"},{"key":"784_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.70026","volume":"34","author":"B Levin","year":"2025","unstructured":"Levin B, et al. Call to action for genetic counseling research in hereditary cancer: considerations from the evidence-based guidelines development process. J Genet Counsel. 2025;34:e70026. https:\/\/doi.org\/10.1002\/jgc4.70026.","journal-title":"J Genet Counsel"},{"key":"784_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100980","volume":"26","author":"JO Culver","year":"2024","unstructured":"Culver JO, et al. Systematic evidence review and meta-analysis of outcomes associated with cancer genetic counseling. Genet Med. 2024;26:100980. https:\/\/doi.org\/10.1016\/j.gim.2023.100980.","journal-title":"Genet Med"},{"key":"784_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082204","author":"MA Subhan","year":"2023","unstructured":"Subhan MA, et al. Recent advances with precision medicine treatment for breast cancer including triple-negative sub-type. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15082204.","journal-title":"Cancers (Basel)"},{"key":"784_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jama.2015.17703","volume":"315","author":"LA Mucci","year":"2016","unstructured":"Mucci LA, et al. Familial risk and heritability of cancer among twins in Nordic countries. JAMA. 2016;315:68\u201376. https:\/\/doi.org\/10.1001\/jama.2015.17703.","journal-title":"JAMA"},{"key":"784_CR62","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1158\/1055-9965.EPI-15-0913","volume":"25","author":"S Moller","year":"2016","unstructured":"Moller S, et al. The heritability of breast cancer among women in the Nordic twin study of cancer. Cancer Epidemiol Biomark Prev. 2016;25:145\u201350. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0913.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"784_CR63","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jgc4.1078","volume":"28","author":"JR Canedo","year":"2019","unstructured":"Canedo JR, Miller ST, Myers HF, Sanderson M. Racial and ethnic differences in knowledge and attitudes about genetic testing in the US: systematic review. J Genet Couns. 2019;28:587\u2013601. https:\/\/doi.org\/10.1002\/jgc4.1078.","journal-title":"J Genet Couns"},{"key":"784_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/ng1096-185","volume":"14","author":"BB Roa","year":"1996","unstructured":"Roa BB, Boyd AA, Volcik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 1996;14:185\u20137. https:\/\/doi.org\/10.1038\/ng1096-185.","journal-title":"Nat Genet"},{"issue":"Suppl 1","key":"784_CR65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/10810730.2016.1144661","volume":"21","author":"KA Kaphingst","year":"2016","unstructured":"Kaphingst KA, et al. Relationships between health literacy and genomics-related knowledge, self-efficacy, perceived importance, and communication in a medically underserved population. J Health Commun. 2016;21(Suppl 1):58\u201368. https:\/\/doi.org\/10.1080\/10810730.2016.1144661.","journal-title":"J Health Commun"},{"key":"784_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11090850","author":"RM Hendricks-Sturrup","year":"2021","unstructured":"Hendricks-Sturrup RM, Joseph L, Lu CY. Patient-reported outcomes following genetic testing for familial hypercholesterolemia, breast and ovarian cancer syndrome, and Lynch syndrome: a systematic review. J Pers Med. 2021. https:\/\/doi.org\/10.3390\/jpm11090850.","journal-title":"J Pers Med"},{"key":"784_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2025.04.044","author":"A Kalra","year":"2025","unstructured":"Kalra A, et al. Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025. https:\/\/doi.org\/10.1016\/j.ajog.2025.04.044.","journal-title":"Am J Obstet Gynecol"},{"key":"784_CR68","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s10897-016-9949-6","volume":"25","author":"J Ringwald","year":"2016","unstructured":"Ringwald J, et al. Psychological distress, anxiety, and depression of cancer-affected BRCA1\/2 mutation carriers: a systematic review. J Genet Couns. 2016;25:880\u201391. https:\/\/doi.org\/10.1007\/s10897-016-9949-6.","journal-title":"J Genet Couns"},{"key":"784_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/GIM.0b013e31815f524f","volume":"10","author":"JT Heshka","year":"2008","unstructured":"Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med. 2008;10:19\u201332. https:\/\/doi.org\/10.1097\/GIM.0b013e31815f524f.","journal-title":"Genet Med"},{"key":"784_CR70","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.esxm.2020.08.002","volume":"8","author":"A Alwaal","year":"2020","unstructured":"Alwaal A, Awad M, Boggs N, Kuzbel J, Snoad B. Sexual health inventory for men questionnaire as a screening method for erectile dysfunction in a general urology clinic. Sex Med. 2020;8:660\u20133. https:\/\/doi.org\/10.1016\/j.esxm.2020.08.002.","journal-title":"Sex Med"},{"key":"784_CR71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/pd.6084","volume":"42","author":"N Vriesen","year":"2022","unstructured":"Vriesen N, Carmany EP, Natoli JL. Clinical outcomes of preimplantation genetic testing for hereditary cancer syndromes: a systematic review. Prenat Diagn. 2022;42:201\u201311. https:\/\/doi.org\/10.1002\/pd.6084.","journal-title":"Prenat Diagn"},{"key":"784_CR72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41431-018-0257-5","volume":"27","author":"T Yanes","year":"2019","unstructured":"Yanes T, Willis AM, Meiser B, Tucker KM, Best M. Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review. Eur J Hum Genet. 2019;27:28\u201335. https:\/\/doi.org\/10.1038\/s41431-018-0257-5.","journal-title":"Eur J Hum Genet"},{"key":"784_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2022.12.010","volume":"129","author":"E Minvielle","year":"2023","unstructured":"Minvielle E, et al. The use of patient-reported outcome and experience measures for health policy purposes: a scoping review in oncology. Health Policy. 2023;129:104702. https:\/\/doi.org\/10.1016\/j.healthpol.2022.12.010.","journal-title":"Health Policy"},{"key":"784_CR74","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737\u201345. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.02.006.","journal-title":"J Clin Epidemiol"},{"key":"784_CR75","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","volume":"27","author":"CB Terwee","year":"2018","unstructured":"Terwee CB, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a delphi study. Qual Life Res. 2018;27:1159\u201370. https:\/\/doi.org\/10.1007\/s11136-018-1829-0.","journal-title":"Qual Life Res"},{"key":"784_CR76","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/s0895-4356(00)00188-8","volume":"53","author":"D Moher","year":"2000","unstructured":"Moher D, et al. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol. 2000;53:964\u201372. https:\/\/doi.org\/10.1016\/s0895-4356(00)00188-8.","journal-title":"J Clin Epidemiol"},{"key":"784_CR77","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ajmg.1320370419","volume":"37","author":"S Shiloh","year":"1990","unstructured":"Shiloh S, Avdor O, Goodman RM. Satisfaction with genetic counseling: dimensions and measurement. Am J Med Genet. 1990;37:522\u20139. https:\/\/doi.org\/10.1002\/ajmg.1320370419.","journal-title":"Am J Med Genet"},{"key":"784_CR78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10689-011-9486-2","volume":"11","author":"E Rothwell","year":"2012","unstructured":"Rothwell E, et al. Patient outcomes associated with group and individual genetic counseling formats. Fam Cancer. 2012;11:97\u2013106. https:\/\/doi.org\/10.1007\/s10689-011-9486-2.","journal-title":"Fam Cancer"},{"key":"784_CR79","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.pec.2013.08.009","volume":"93","author":"L Patrick-Miller","year":"2013","unstructured":"Patrick-Miller L, et al. Implementation and outcomes of telephone disclosure of clinical BRCA1\/2 test results. Patient Educ Couns. 2013;93:413\u20139. https:\/\/doi.org\/10.1016\/j.pec.2013.08.009.","journal-title":"Patient Educ Couns"},{"key":"784_CR80","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.4564","volume":"18","author":"A Bradbury","year":"2016","unstructured":"Bradbury A, et al. Utilizing remote real-time videoconferencing to expand access to cancer genetic services in community practices: a multicenter feasibility study. J Med Internet Res. 2016;18:e23. https:\/\/doi.org\/10.2196\/jmir.4564.","journal-title":"J Med Internet Res"},{"key":"784_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10689-021-00240-6","volume":"21","author":"RA Pozzar","year":"2022","unstructured":"Pozzar RA, et al. Knowledge and psychosocial impact of genetic counseling and multigene panel testing among individuals with ovarian cancer. Fam Cancer. 2022;21:35\u201347. https:\/\/doi.org\/10.1007\/s10689-021-00240-6.","journal-title":"Fam Cancer"},{"key":"784_CR82","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/jnci\/djy015","volume":"110","author":"AR Bradbury","year":"2018","unstructured":"Bradbury AR, et al. Randomized noninferiority trial of telephone vs in-person disclosure of germline cancer genetic test results. J Natl Cancer Inst. 2018;110:985\u201393. https:\/\/doi.org\/10.1093\/jnci\/djy015.","journal-title":"J Natl Cancer Inst"},{"key":"784_CR83","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1002\/cncr.28807","volume":"120","author":"PS Blanchette","year":"2014","unstructured":"Blanchette PS, et al. Genomic testing in cancer: patient knowledge, attitudes, and expectations. Cancer. 2014;120:3066\u201373. https:\/\/doi.org\/10.1002\/cncr.28807.","journal-title":"Cancer"},{"key":"784_CR84","doi-asserted-by":"publisher","DOI":"10.1177\/2381468317692582","author":"MM Langer","year":"2017","unstructured":"Langer MM, et al. Development and validation of a genomic knowledge scale to advance informed decision making research in genomic sequencing. MDM Policy Pract. 2017. https:\/\/doi.org\/10.1177\/2381468317692582.","journal-title":"MDM Policy Pract"},{"key":"784_CR85","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/pon.4733","volume":"27","author":"JG Hamilton","year":"2018","unstructured":"Hamilton JG, et al. Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives. Psychooncology. 2018;27:1825\u201332. https:\/\/doi.org\/10.1002\/pon.4733.","journal-title":"Psychooncology"},{"key":"784_CR86","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5694\/mja2.51906","volume":"218","author":"DL De Silva","year":"2023","unstructured":"De Silva DL, et al. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care. Med J Aust. 2023;218:368\u201373. https:\/\/doi.org\/10.5694\/mja2.51906.","journal-title":"Med J Aust"},{"key":"784_CR87","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jamaoncol.2015.3048","volume":"1","author":"J Armstrong","year":"2015","unstructured":"Armstrong J, et al. Utilization and outcomes of BRCA genetic testing and counseling in a national commercially insured population: the ABOUT study. JAMA Oncol. 2015;1:1251\u201360. https:\/\/doi.org\/10.1001\/jamaoncol.2015.3048.","journal-title":"JAMA Oncol"},{"key":"784_CR88","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(sici)1096-8628(19990101)82:1","volume":"82","author":"M Berkenstadt","year":"1999","unstructured":"Berkenstadt M, Shiloh S, Barkai G, Katznelson MB, Goldman B. Perceived personal control (PPC): a new concept in measuring outcome of genetic counseling. Am J Med Genet. 1999;82:53\u20139. https:\/\/doi.org\/10.1002\/(sici)1096-8628(19990101)82:1.","journal-title":"Am J Med Genet"},{"key":"784_CR89","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3390\/curroncol28020138","volume":"28","author":"JM McCuaig","year":"2021","unstructured":"McCuaig JM, et al. A comparison of patient-reported outcomes following consent for genetic testing using an oncologist- or genetic counselor-mediated model of care. Curr Oncol. 2021;28:1459\u201371. https:\/\/doi.org\/10.3390\/curroncol28020138.","journal-title":"Curr Oncol"},{"key":"784_CR90","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/jgc4.1661","volume":"32","author":"JM McCuaig","year":"2023","unstructured":"McCuaig JM, et al. Patient-reported outcomes associated with reflex BRCA1\/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer. J Genet Counsel. 2023;32:503\u201313. https:\/\/doi.org\/10.1002\/jgc4.1661.","journal-title":"J Genet Counsel"},{"key":"784_CR91","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13053-022-00221-5","volume":"20","author":"JM McCuaig","year":"2022","unstructured":"McCuaig JM, et al. Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think? Hered Cancer Clin Pract. 2022;20:15. https:\/\/doi.org\/10.1186\/s13053-022-00221-5.","journal-title":"Hered Cancer Clin Pract"},{"key":"784_CR92","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/GIM.0b013e3181993175","volume":"11","author":"NA Kasparian","year":"2009","unstructured":"Kasparian NA, Meiser B, Butow PN, Simpson JM, Mann GJ. Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families. Genet Med. 2009;11:265\u201378. https:\/\/doi.org\/10.1097\/GIM.0b013e3181993175.","journal-title":"Genet Med"},{"key":"784_CR93","doi-asserted-by":"publisher","first-page":"29506","DOI":"10.1038\/srep29506","volume":"6","author":"A George","year":"2016","unstructured":"George A, et al. Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci Rep. 2016;6:29506. https:\/\/doi.org\/10.1038\/srep29506.","journal-title":"Sci Rep"},{"key":"784_CR94","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4428","volume":"2","author":"Z Kemp","year":"2019","unstructured":"Kemp Z, et al. Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Netw Open. 2019;2:e194428. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.4428.","journal-title":"JAMA Netw Open"},{"key":"784_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020338","author":"M Richardson","year":"2020","unstructured":"Richardson M, et al. Oncology clinic-based hereditary cancer genetic testing in a population-based health care system. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12020338.","journal-title":"Cancers (Basel)"},{"key":"784_CR96","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jgc4.1512","volume":"31","author":"Z Lohn","year":"2022","unstructured":"Lohn Z, et al. Large-scale group genetic counseling: evaluation of a novel service delivery model in a Canadian hereditary cancer clinic. J Genet Couns. 2022;31:459\u201369. https:\/\/doi.org\/10.1002\/jgc4.1512.","journal-title":"J Genet Couns"},{"key":"784_CR97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10897-006-9048-1","volume":"16","author":"AH Pieterse","year":"2007","unstructured":"Pieterse AH, van Dulmen AM, Beemer FA, Bensing JM, Ausems MG. Cancer genetic counseling: communication and counselees\u2019 post-visit satisfaction, cognitions, anxiety, and needs fulfillment. J Genet Couns. 2007;16:85\u201396. https:\/\/doi.org\/10.1007\/s10897-006-9048-1.","journal-title":"J Genet Couns"},{"key":"784_CR98","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2217\/pgs-2017-0191","volume":"19","author":"AA Lemke","year":"2018","unstructured":"Lemke AA, et al. Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Pharmacogenomics. 2018;19:321\u201331. https:\/\/doi.org\/10.2217\/pgs-2017-0191.","journal-title":"Pharmacogenomics"},{"key":"784_CR99","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10897-018-0286-9","volume":"28","author":"M Li","year":"2019","unstructured":"Li M, et al. The feelings about genomic testing results (FACToR) questionnaire: development and preliminary validation. J Genet Couns. 2019;28:477\u201390. https:\/\/doi.org\/10.1007\/s10897-018-0286-9.","journal-title":"J Genet Couns"},{"key":"784_CR100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13073-019-0619-9","volume":"11","author":"ES Zoltick","year":"2019","unstructured":"Zoltick ES, et al. Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq consortium. Genome Med. 2019;11:10. https:\/\/doi.org\/10.1186\/s13073-019-0619-9.","journal-title":"Genome Med"},{"key":"784_CR101","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/gte.2007.0037","volume":"12","author":"E Finlay","year":"2008","unstructured":"Finlay E, et al. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1\/2 mutations. Genet Test. 2008;12:81\u201391. https:\/\/doi.org\/10.1089\/gte.2007.0037.","journal-title":"Genet Test"},{"key":"784_CR102","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1200\/JCO.2005.01.7541","volume":"24","author":"AF Patenaude","year":"2006","unstructured":"Patenaude AF, et al. Sharing BRCA1\/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol. 2006;24:700\u20136. https:\/\/doi.org\/10.1200\/JCO.2005.01.7541.","journal-title":"J Clin Oncol"},{"key":"784_CR103","doi-asserted-by":"publisher","first-page":"966","DOI":"10.7326\/0003-4819-127-11-199712010-00003","volume":"127","author":"LM Schwartz","year":"1997","unstructured":"Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997;127:966\u201372. https:\/\/doi.org\/10.7326\/0003-4819-127-11-199712010-00003.","journal-title":"Ann Intern Med"},{"key":"784_CR104","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1177\/0272989X07304449","volume":"27","author":"A Fagerlin","year":"2007","unstructured":"Fagerlin A, et al. Measuring numeracy without a math test: development of the subjective numeracy scale. Med Decis Making. 2007;27:672\u201380. https:\/\/doi.org\/10.1177\/0272989X07304449.","journal-title":"Med Decis Making"},{"key":"784_CR105","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/0272989X07303824","volume":"27","author":"BJ Zikmund-Fisher","year":"2007","unstructured":"Zikmund-Fisher BJ, Smith DM, Ubel PA, Fagerlin A. Validation of the subjective numeracy scale: effects of low numeracy on comprehension of risk communications and utility elicitations. Med Decis Making. 2007;27:663\u201371. https:\/\/doi.org\/10.1177\/0272989X07303824.","journal-title":"Med Decis Making"},{"key":"784_CR106","first-page":"588","volume":"36","author":"LD Chew","year":"2004","unstructured":"Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36:588\u201394.","journal-title":"Fam Med"},{"key":"784_CR107","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1200\/JCO.2003.01.088","volume":"21","author":"MD Schwartz","year":"2003","unstructured":"Schwartz MD, et al. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1\/BRCA2 mutation testing. J Clin Oncol. 2003;21:4034\u201341. https:\/\/doi.org\/10.1200\/JCO.2003.01.088.","journal-title":"J Clin Oncol"},{"key":"784_CR108","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s10897-016-0050-y","volume":"26","author":"NA Morman","year":"2017","unstructured":"Morman NA, Byrne L, Collins C, Reynolds K, Bell JG. Breast cancer risk assessment at the time of screening mammography: perceptions and clinical management outcomes for women at high risk. J Genet Counsel. 2017;26:776\u201384. https:\/\/doi.org\/10.1007\/s10897-016-0050-y.","journal-title":"J Genet Counsel"},{"key":"784_CR109","first-page":"345","volume":"8","author":"AM Codori","year":"1999","unstructured":"Codori AM, et al. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev. 1999;8:345\u201351.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"784_CR110","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"784_CR111","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00520-009-0594-6","volume":"17","author":"C Bjorvatn","year":"2009","unstructured":"Bjorvatn C, Eide GE, Hanestad BR, Hamang A, Havik OE. Intrusion and avoidance in subjects undergoing genetic investigation and counseling for hereditary cancer. Support Care Cancer. 2009;17:1371\u201381. https:\/\/doi.org\/10.1007\/s00520-009-0594-6.","journal-title":"Support Care Cancer"},{"key":"784_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2022.101033","volume":"42","author":"KE Dibble","year":"2022","unstructured":"Dibble KE, Donorfio LKM, Britner PA, Bellizzi KM. Stress, anxiety, and health-related quality of life in BRCA1\/2-positive women with and without cancer: a comparison of four US female samples. Gynecol Oncol Rep. 2022;42:101033. https:\/\/doi.org\/10.1016\/j.gore.2022.101033.","journal-title":"Gynecol Oncol Rep"},{"key":"784_CR113","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr.","year":"1996","unstructured":"Ware J Jr., Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220\u201333. https:\/\/doi.org\/10.1097\/00005650-199603000-00003.","journal-title":"Med Care"},{"key":"784_CR114","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365.","journal-title":"J Natl Cancer Inst"},{"key":"784_CR115","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol"},{"key":"784_CR116","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319\u201326. https:\/\/doi.org\/10.1038\/sj.ijir.3900472.","journal-title":"Int J Impot Res"},{"key":"784_CR117","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/s0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549\u201357. https:\/\/doi.org\/10.1016\/s0022-5347(17)36966-5. (discussion 1564).","journal-title":"J Urol"},{"key":"784_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247902","volume":"16","author":"R Gomez","year":"2021","unstructured":"Gomez R, Stavropoulos V, Zarate D, Palikara O. Symptom checklist-90-revised: a structural examination in relation to family functioning. PLoS ONE. 2021;16:e0247902. https:\/\/doi.org\/10.1371\/journal.pone.0247902.","journal-title":"PLoS ONE"},{"key":"784_CR119","first-page":"13","volume":"9","author":"LR Derogatis","year":"1973","unstructured":"Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale\u2014preliminary report. Psychopharmacol Bull. 1973;9:13\u201328.","journal-title":"Psychopharmacol Bull"},{"key":"784_CR120","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1017\/S0033291700048017","volume":"13","author":"LR Derogatis","year":"1983","unstructured":"Derogatis LR, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med. 1983;13:595\u2013605.","journal-title":"Psychol Med"},{"key":"784_CR121","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/PRBM.S173282","volume":"12","author":"M Adawi","year":"2019","unstructured":"Adawi M, et al. Psychometric properties of the Brief Symptom Inventory in nomophobic subjects: insights from preliminary confirmatory factor, exploratory factor, and clustering analyses in a sample of healthy Italian volunteers. Psychol Res Behav Manag. 2019;12:145\u201354. https:\/\/doi.org\/10.2147\/PRBM.S173282.","journal-title":"Psychol Res Behav Manag"},{"key":"784_CR122","unstructured":"Braehler WSJ. The Giessen Complaints Inventory (German). (1995)."},{"key":"784_CR123","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s12282-019-01033-7","volume":"27","author":"LSE van Egdom","year":"2020","unstructured":"van Egdom LSE, et al. Patient-reported outcome measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers. Breast Cancer. 2020;27:426\u201334. https:\/\/doi.org\/10.1007\/s12282-019-01033-7.","journal-title":"Breast Cancer"},{"key":"784_CR124","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-u","volume":"33","author":"PF Lovibond","year":"1995","unstructured":"Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33:335\u201343. https:\/\/doi.org\/10.1016\/0005-7967(94)00075-u.","journal-title":"Behav Res Ther"},{"key":"784_CR125","doi-asserted-by":"crossref","unstructured":"Lovibond SHL, PF Manual for the depression anxiety stress scales. 2nd Ed edn, (1995).","DOI":"10.1037\/t01004-000"},{"key":"784_CR126","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1348\/014466505X29657","volume":"44","author":"JD Henry","year":"2005","unstructured":"Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005;44:227\u201339. https:\/\/doi.org\/10.1348\/014466505X29657.","journal-title":"Br J Clin Psychol"},{"key":"784_CR127","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s41687-019-0150-1","volume":"3","author":"R Touzani","year":"2019","unstructured":"Touzani R, et al. Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men. J Patient Rep Outcomes. 2019;3:60. https:\/\/doi.org\/10.1186\/s41687-019-0150-1.","journal-title":"J Patient Rep Outcomes"},{"key":"784_CR128","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1002\/cncr.11386","volume":"97","author":"AJ Roth","year":"2003","unstructured":"Roth AJ, et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer. 2003;97:2910\u20138. https:\/\/doi.org\/10.1002\/cncr.11386.","journal-title":"Cancer"},{"key":"784_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113223","volume":"291","author":"AN Zsido","year":"2020","unstructured":"Zsido AN, Teleki SA, Csokasi K, Rozsa S, Bandi SA. Development of the short version of the spielberger state-trait anxiety inventory. Psychiatry Res. 2020;291:113223. https:\/\/doi.org\/10.1016\/j.psychres.2020.113223.","journal-title":"Psychiatry Res"},{"key":"784_CR130","unstructured":"GA, SCGRLRVPJ. Manual for the State-Trait Anxiety Inventory (Form Y). Mind Garden, Inc, (1983)."},{"key":"784_CR131","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.breast.2019.10.013","volume":"49","author":"F Penault-Llorca","year":"2020","unstructured":"Penault-Llorca F, et al. Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: a prospective multicenter trial assessing the clinical and psychological impact of EndoPredict\u00ae (EpClin) use (UCBG 2\u201314). Breast. 2020;49:132\u201340. https:\/\/doi.org\/10.1016\/j.breast.2019.10.013.","journal-title":"Breast"},{"key":"784_CR132","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"key":"784_CR133","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1176\/appi.psy.50.6.613","volume":"50","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50:613\u201321. https:\/\/doi.org\/10.1176\/appi.psy.50.6.613.","journal-title":"Psychosomatics"},{"key":"784_CR134","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385\u201396.","journal-title":"J Health Soc Behav"},{"key":"784_CR135","volume-title":"Perceived stress in a probability sample of the United States","author":"SAWG Cohen","year":"1988","unstructured":"Cohen SAWG. Perceived stress in a probability sample of the United States. The Social Psychology of Health; 1988."},{"key":"784_CR136","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11764-014-0383-1","volume":"9","author":"B Thewes","year":"2015","unstructured":"Thewes B, Zachariae R, Christensen S, Nielsen T, Butow P. The concerns about recurrence questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surviv. 2015;9:68\u201379. https:\/\/doi.org\/10.1007\/s11764-014-0383-1.","journal-title":"J Cancer Surviv"},{"key":"784_CR137","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00225","author":"SJ Katz","year":"2018","unstructured":"Katz SJ, et al. Association of germline genetic test type and results with patient cancer worry after diagnosis of breast cancer. JCO Precis Oncol. 2018. https:\/\/doi.org\/10.1200\/PO.18.00225.","journal-title":"JCO Precis Oncol"},{"key":"784_CR138","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1023\/a:1023078521319","volume":"26","author":"MD Schwartz","year":"2003","unstructured":"Schwartz MD, Taylor KL, Willard KS. Prospective association between distress and mammography utilization among women with a family history of breast cancer. J Behav Med. 2003;26:105\u201317. https:\/\/doi.org\/10.1023\/a:1023078521319.","journal-title":"J Behav Med"},{"key":"784_CR139","first-page":"175","volume":"10","author":"KK Ownby","year":"2019","unstructured":"Ownby KK. Use of the distress thermometer in clinical practice. J Adv Pract Oncol. 2019;10:175\u20139.","journal-title":"J Adv Pract Oncol"},{"key":"784_CR140","doi-asserted-by":"publisher","first-page":"344","DOI":"10.6004\/jnccn.2003.0031","volume":"1","author":"National Comprehensive Cancer, N","year":"2003","unstructured":"National Comprehensive Cancer, N. Distress management. Clinical practice guidelines. J Natl Compr Canc Netw. 2003;1:344\u201374. https:\/\/doi.org\/10.6004\/jnccn.2003.0031.","journal-title":"J Natl Compr Canc Netw"},{"key":"784_CR141","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-016-3780-5","volume":"156","author":"CN Evans","year":"2016","unstructured":"Evans CN, et al. Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy. Breast Cancer Res Treat. 2016;156:549\u201355. https:\/\/doi.org\/10.1007\/s10549-016-3780-5.","journal-title":"Breast Cancer Res Treat"},{"key":"784_CR142","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/0272989X9601600114","volume":"16","author":"M Holmes-Rovner","year":"1996","unstructured":"Holmes-Rovner M, et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making. 1996;16:58\u201364. https:\/\/doi.org\/10.1177\/0272989X9601600114.","journal-title":"Med Decis Making"},{"key":"784_CR143","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0738-3991(01)00218-x","volume":"47","author":"A Cranney","year":"2002","unstructured":"Cranney A, et al. Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Educ Couns. 2002;47:245\u201355. https:\/\/doi.org\/10.1016\/s0738-3991(01)00218-x.","journal-title":"Patient Educ Couns"},{"key":"784_CR144","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989X03256005","volume":"23","author":"JC Brehaut","year":"2003","unstructured":"Brehaut JC, et al. Validation of a decision regret scale. Med Decis Making. 2003;23:281\u201392. https:\/\/doi.org\/10.1177\/0272989X03256005.","journal-title":"Med Decis Making"},{"key":"784_CR145","first-page":"21","volume":"29","author":"LF Degner","year":"1997","unstructured":"Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res. 1997;29:21\u201343.","journal-title":"Can J Nurs Res"},{"key":"784_CR146","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1399-0004.2011.01636.x","volume":"79","author":"M McAllister","year":"2011","unstructured":"McAllister M, Wood AM, Dunn G, Shiloh S, Todd C. The genetic counseling outcome scale: a new patient-reported outcome measure for clinical genetics services. Clin Genet. 2011;79:413\u201324. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01636.x.","journal-title":"Clin Genet"},{"key":"784_CR147","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/pon.853","volume":"14","author":"A Pieterse","year":"2005","unstructured":"Pieterse A, et al. Quote-gene(ca): development of a counselee-centered instrument to measure needs and preferences in genetic counseling for hereditary cancer. Psychooncology. 2005;14:361\u201375. https:\/\/doi.org\/10.1002\/pon.853.","journal-title":"Psychooncology"},{"key":"784_CR148","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10897-012-9519-5","volume":"22","author":"S Salemink","year":"2013","unstructured":"Salemink S, et al. Focusing on patient needs and preferences may improve genetic counseling for colorectal cancer. J Genet Counsel. 2013;22:118\u201324. https:\/\/doi.org\/10.1007\/s10897-012-9519-5.","journal-title":"J Genet Counsel"},{"key":"784_CR149","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/jmg.39.9.689","volume":"39","author":"K Nordin","year":"2002","unstructured":"Nordin K, Liden A, Hansson M, Rosenquist R, Berglund G. Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer. J Med Genet. 2002;39:689\u201394. https:\/\/doi.org\/10.1136\/jmg.39.9.689.","journal-title":"J Med Genet"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-025-00784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-025-00784-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-025-00784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:11:39Z","timestamp":1772014299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-025-00784-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":149,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1007\/s40271-025-00784-0","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This review was not registered, and a protocol was not prepared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registration and Protocol"}},{"value":"The review materials are not publicly available.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data, Code and Other Materials"}},{"value":"KR, JLD and JR conceived the review topic. DN performed the PubMed search, and KR and DN reviewed the titles and abstracts. KR and JR reviewed the full texts and recorded the key information. KR wrote the original draft and formatted the figures and tables. All authors reviewed and edited the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}